Mediwound Ltd (MDWD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $185.63M
Last updated: Nov 17, 2026 at 11:04 AM ET
Mediwound Ltd (MDWD) Competitors
The companies most similar to Mediwound are Sol Gel Technologies (SLGL), CorMedix (CRMD) and Upstream Bio (UPB). By market cap, Mediwound ranks 5th of the 13 companies on this page; CorMedix (CRMD) is the largest at $370.64M.
Peer Comparison
MDWD's revenue growth of -34.2% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Mediwound (MDWD) | $185.63M | N/A | 17.6x | -235.0% | -66.9% | -34.2% | 0.00% |
| Sol Gel Technologies Ltd (SLGL) | $180.46M | N/A | 125.4x | 0.0% | N/A | -96.6% | 0.00% |
| CorMedix Inc (CRMD) | $370.64M | 6.3x | 0.9x | 15.5% | 13.9% | -47.7% | 0.00% |
| Upstream Bio, Inc. (UPB) | $152.38M | N/A | 41.0x | 0.0% | N/A | -42.2% | 0.00% |
| Whitehawk Therapeutics, Inc. (WHWK) | $180.57M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| PolyPid (PYPD) | $132.25M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Invivyd Inc. (IVVD) | $171.58M | N/A | 2.9x | -183.9% | N/A | 21.2% | 0.00% |
| Palisade Bio Inc (PALI) | $201.01M | N/A | 436.8x | 0.0% | N/A | 0.0% | 0.00% |
| Zentalis Pharmaceuticals Llc (ZNTL) | $167.05M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Protalix Biotherapeutics Inc (PLX) | $257.17M | 12.1x | 2.9x | 24.3% | N/A | 22.8% | 0.00% |
| Atrium Therapeutics, Inc. Common Stock (RNA) | $162.00M | N/A | 3.3x | -180.9% | -44.5% | 24.2% | 0.00% |
| Immunic Inc (IMUX) | $102.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Keros Therapeutics Inc (KROS) | $202.13M | N/A | 4.9x | -151.4% | N/A | 180.5% | 0.00% |
| Peer median | $176.02M | 9.2x | 4.1x | 0.0% | -15.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Mediwound, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Sol Gel Technologies Ltd (SLGL) | Sol-Gel Technologies Ltd., a specialty clinical-stage pharmaceutical company, is focused on developing and commercializing topical dermatological... | SLGL competitors |
| CorMedix Inc (CRMD) | CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious... | CRMD competitors |
| Upstream Bio, Inc. (UPB) | Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. | UPB competitors |
| Whitehawk Therapeutics, Inc. (WHWK) | Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. | WHWK competitors |
| PolyPid (PYPD) | PolyPid Ltd., an advanced stage biopharmaceutical company, develops, manufactures and markets products based on the Polymer Lipid Encapsulation Matrix (PLEX)... | PYPD competitors |
| Invivyd Inc. (IVVD) | Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery... | IVVD competitors |
| Palisade Bio Inc (PALI) | Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. | PALI competitors |
| Zentalis Pharmaceuticals Llc (ZNTL) | Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment... | ZNTL competitors |
| Protalix Biotherapeutics Inc (PLX) | Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its... | PLX competitors |
| Atrium Therapeutics, Inc. Common Stock (RNA) | Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. | RNA competitors |
| Immunic Inc (IMUX) | Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune... | IMUX competitors |
| Keros Therapeutics Inc (KROS) | Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery... | KROS competitors |
Frequently Asked Questions About MDWD
Who are Mediwound's main competitors?
The companies most similar to Mediwound include Sol Gel Technologies (SLGL), CorMedix (CRMD), Upstream Bio (UPB), Whitehawk Therapeutics (WHWK) and PolyPid (PYPD), listed from the closest match.
Who is Mediwound's biggest competitor?
CorMedix (CRMD) is the largest of the similar companies at $370.64M; Sol Gel Technologies (SLGL) is the closest match by business profile, size, sector and industry.
How does MDWD stock compare with its competitors?
MDWD's P/S is 17.6x against a peer median of 4.1x; its net margin is -235.0% against a peer median of 0.0%.
Which of Mediwound's competitors pays a higher dividend?
Mediwound pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Mediwound bigger than its competitors?
No. Mediwound is 5th by market cap among the 13 companies on this page; the largest is CorMedix (CRMD) at $370.64M.
MDWD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts